Federal regulators are taking a second stab at banning the controversial use of electroshock devices to manage the behavior of patients with intellectual and developmental disorders.
The devices deliver electric shocks to a patient's skin, in an attempt to stop them from harming themselves or lashing out physically at others, the U.S. Food and Drug Administration said in its Monday announcement.
“Since ESDs were first marketed more than 20 years ago, we have gained a better understanding of the danger these devices present to public health,” Dr. William Maisel, director of the Office of Product Evaluation and Quality in the FDA's Center for Devices and Radiological Health, said in a news release at the time of the first ban.
The Rotenberg Center's website says that it provides treatment for both children and adults. Some students live at the facility, while others take day classes.Critics argued that the electrical shock devices were used excessively, causing lasting damage to students. “The FDA intends to consider the needs of these patients should we finalize the proposed ban,” the agency said in its statement.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
FDA proposes ban on electrical shock devices used to stop aggressive behavior for the second timeThe FDA has proposed banning electrical stimulation devices used to reduce or stop self-injurious or aggressive behavior due to the risk of injury they pose.
Les mer »
Telehealth sites promise cure for ‘male menopause’ despite FDA ban on off-label adsIn 2015, the FDA said it banned 'low-t' television ads for exaggerating to scare men into buying drugs. Now the ads have moved online.
Les mer »
FDA’s plan to ban hair relaxer chemical called too little, too lateThe New Black View
Les mer »
Telehealth websites promise cure for 'male menopause' despite FDA ban on off-label adsMost healthy men produce sufficient testosterone as they age. Yet online ads and telehealth sites are promoting testosterone drugs with flawed promises of boosting libido and busting stomach fat.
Les mer »
Certain ground cinnamon may have high levels of lead, FDA warnsGround cinnamon sold in U.S. discount stores is contaminated with high levels of lead and should be discarded.
Les mer »
Amylyx May Pull FDA-Approved ALS Drug After Failed Phase 3 TrialTopline results for the ALS drug Relyvrio show that it failed to meet primary or secondary endpoints. The company says it may voluntarily pull the drug from the market.
Les mer »